Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

HYLORIS PHARMACEUTICALS SA

(HYL)
  Report
Real-time Euronext Bruxelles  -  10:56 2022-09-27 am EDT
13.02 EUR   -0.91%
09/06Pleco Therapeutics B.V. announced that it has received €4.6 million in funding from Hyloris Pharmaceuticals SA, Oost NL BV
CI
09/06Pleco Therapeutics B.V. announced that it has received funding from Oost NL BV, Hyloris Pharmaceuticals SA
CI
09/01Hyloris Pharmaceuticals Reports 2022 Half-Year Results and Provides Corporate Update
GL
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Official Publications
09/01/22Half-year report 
09/01/221st-half-year results 
09/01/221st-half-year results 
07/05/22Threshold crossings 
06/14/22Minutes of the general assembly 
05/13/22Mixed general shareholder meeting 
05/13/22Mixed general shareholder meeting 
04/30/22Management Report 
04/30/22Annual Report 
04/30/22Annual Report 
04/29/22Auditors Report 
04/29/22Auditors Report 
04/05/22Threshold crossings 
03/16/22Annual results 
03/16/22Annual results 
08/04/21Half-year report 
08/04/21Half-year report 
06/08/21Minutes of the general assembly 
06/08/21Minutes of the general assembly 
05/07/21Mixed general shareholder meeting 
05/07/21Mixed general shareholder meeting 
04/30/21Annual Report 
04/30/21Annual Report 
03/09/21Annual results 
03/09/21Annual results 
11/27/20Monthly statement on voting rights 
11/27/20Monthly statement on voting rights 
07/31/20Threshold crossings 
07/31/20Threshold crossings 
07/07/20Threshold crossings 
06/30/20Half-year report 
06/30/20Half-year report 
06/17/20Stock market flotation 
06/17/20Stock market flotation 
Upcoming event on HYLORIS PHARMACEUTICALS SA